{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:51:27Z","timestamp":1774122687254,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>This study aimed to evaluate the clinical safety and validate the radiomitigative effect of KMRC011, against radiation-induced oral mucositis in beagle dogs. Clinical safety was evaluated by assessing tolerability, complete blood tests, and plasma biochemistry after drug administration. The radiomitigative effect of KMRC011 was evaluated macropathologically and histopathologically after inducing oral mucositis iatrogenically using 20 Gy irradiation. The plasma concentration of interleukin-6 was measured <jats:italic>via<\/jats:italic> enzyme-linked immunosorbent assay, as a biomarker of KMRC011 bioreactivity. Decreased tolerability, increased neutrophil count, hepatic enzyme concentration, C-reactive protein concentration, and interleukin-6 concentration after the administration was observed and ceased within 24 h without additional treatment. Although all animals included in the present study developed severe mucositis in the late course of the study, animals administered KMRC011 showed less erythema, ulcer, inflammatory infiltration. These results suggest that KMRC011 may be used as an adjuvant for radiotherapy without severe adverse effects, especially during short-term radiotherapy, such as hypofractionated radiotherapy or stereotactic radiotherapy.<\/jats:p>","DOI":"10.3389\/fvets.2022.839467","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:44:19Z","timestamp":1660286659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical evaluation of toll-like receptor-5 agonist for radiation-induced oral mucositis in beagle dogs"],"prefix":"10.3389","volume":"9","author":[{"given":"Jaeeun","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Kyu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Soep","family":"Nahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Min","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woojong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weon Kuu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kidong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1038\/sj.onc.1206702","article-title":"Radiation and ceramide-induced apoptosis","volume":"22","author":"Kolesnick","year":"2003","journal-title":"Oncogene."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4317\/jced.3.e31","article-title":"Dental treatment considerations in the chemotherapy patient","author":"Chaveli Lopez","year":"2011","journal-title":"J Clin Exp Dent"},{"key":"B3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1368-8375(99)00033-0","article-title":"Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review","volume":"35","author":"Plevov\u00e1","year":"1999","journal-title":"Oral Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00066-012-0128-x","article-title":"Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70\u201375 Gy in 5 weeks for advanced head and neck cancer: a phase I dose escalation study","volume":"188","author":"Cvek","year":"2012","journal-title":"Strahlenther Onkol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00066-013-0311-8","article-title":"Acute mucosal reactions in patients with head and neck cancer: three patterns of mucositis observed during radiotherapy","volume":"189","author":"Wygoda","year":"2013","journal-title":"Strahlenther Onkol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fonc.2017.00089","article-title":"Radiation-induced oral mucositis","volume":"7","author":"Maria","year":"2017","journal-title":"Front Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/cncr.23898","article-title":"Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy","volume":"113","author":"Elting","year":"2008","journal-title":"Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int J Radiat Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer."},{"key":"B11","unstructured":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0135388","DOI":"10.1371\/journal.pone.0135388","article-title":"The toll-like receptor 5 agonist entolimod mitigates lethal acute radiation syndrome in non-human primates","volume":"10","author":"Krivokrysenko","year":"2015","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1126\/science.1154986","article-title":"An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models","volume":"320","author":"Burdelya","year":"2008","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1107\/S0907444906052024","article-title":"His-tag impact on structure","volume":"63","author":"Carson","year":"2007","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/jrr\/rrz024","article-title":"Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation","volume":"60","author":"Kim","year":"2019","journal-title":"J Radiat Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.bbrc.2018.11.080","article-title":"Yoon S. TLR5 binding and activation by KMRC011, a flagellin-derived radiation countermeasure","volume":"508","author":"Song","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/1547691X.2019.1699617","article-title":"KMRC011, an agonist of toll-like receptor 5, mitigates irradiation-induced tissue damage and mortality in cynomolgus monkeys","volume":"17","author":"Lee","year":"2020","journal-title":"J Immunotoxicol"},{"key":"B18","unstructured":"Stereotactic radiation therapy in veterinary medicine957\n            BloomfieldR\n          30822372Can Vet J.562015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1476-5829.2011.00270.x","article-title":"Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases","volume":"10","author":"Berlato","year":"2012","journal-title":"Vet Comp Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/jpet.112.196071","article-title":"Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure","volume":"343","author":"Krivokrysenko","year":"2012","journal-title":"J Pharmacol Exp Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"cts","DOI":"10.1111\/cts.13073","article-title":"A first-in-human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics","volume":"14","author":"Yang","year":"2021","journal-title":"Clin Transl Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/1753425920901862","article-title":"Characterisation and functional analysis of canine TLR5","volume":"26","author":"Zhu","year":"2020","journal-title":"Innate Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/09629359791677","article-title":"Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells","volume":"6","author":"Meeren","year":"1997","journal-title":"Mediators Inflamm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"G767","DOI":"10.1152\/ajpgi.00447.2006","article-title":"Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells","volume":"292","author":"Sun","year":"2007","journal-title":"Am J Physiol - Gastrointest Liver Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/odi.12287","article-title":"Histopathologic grading of oral mucositis","volume":"21","author":"Sunavala-Dossabhoy","year":"2015","journal-title":"Oral Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/00365510600889635","article-title":"Systemic and local cytokine patterns during total hip surgery","volume":"66","author":"Clementsen","year":"2006","journal-title":"Scand J Clin Lab Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1086\/499824","article-title":"Local and systemic cytokine levels in relation to changes in vaginal flora","volume":"193","author":"Hedge","year":"2006","journal-title":"J Infect Dis."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.839467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:44:22Z","timestamp":1660286662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.839467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":27,"alternative-id":["10.3389\/fvets.2022.839467"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.839467","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"article-number":"839467"}}